Mankind Pharma Ltd Capital Reinvestment Ratio
Mankind Pharma Ltd capital reinvestment ratio. Mankind Pharma Ltd (MANKIND) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs16.37 Billion) in capital expenditures (Rs2.71 Billion). See Mankind Pharma Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Mankind Pharma Ltd (2019–2026)
Capital reinvestment ratio of Mankind Pharma Ltd from 2019 to 2026. This chart tracks Mankind Pharma Ltd's Capital Reinvestment Ratio across 8 annual periods. See financial flexibility index of Mankind Pharma Ltd to measure the company's free cash flow as a share of total liabilities.
Mankind Pharma Ltd Capital Reinvestment Ratio by Year (2019–2026)
Mankind Pharma Ltd capital reinvestment ratio by year from 2019 to 2026. For the full cash flow conversion analysis, see MANKIND cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.25x | Rs25.16 Billion | Rs6.26 Billion | ▲ +30.3% |
| 2025 | 0.19x | Rs24.13 Billion | Rs4.61 Billion | ▲ +7.5% |
| 2024 | 0.18x | Rs21.52 Billion | Rs3.82 Billion | ▼ -61.3% |
| 2023 | 0.46x | Rs18.13 Billion | Rs8.32 Billion | ▼ -82.0% |
| 2022 | 2.55x | Rs9.20 Billion | Rs23.46 Billion | ▲ +828.6% |
| 2021 | 0.27x | Rs11.37 Billion | Rs3.12 Billion | ▲ +28.9% |
| 2020 | 0.21x | Rs10.70 Billion | Rs2.28 Billion | ▼ -57.0% |
| 2019 | 0.50x | Rs6.00 Billion | Rs2.98 Billion | — |